Trial
|
Studied treatment |
Control |
Patients |
Size |
Study type
|
Results |
NCT |
Cardiovascular prevention - antioxydants in all type of patients - antioxydants in primary prevention - antioxydants in secondary prevention - antioxydants in patients with renal disease |
GISSI, 1999 | vitamin E | control | | 11324 (5660/5664) | Confirmatory - | | |
PPP, 2001 | vitamin E | control | | 4495 (2231/2264) | Confirmatory - | | |
CHAOS, 1996 | vitamin E | placebo | | 2002 (1035/967) | Exploratory | | |
SPACE, 2000 | vitamin E | placebo | | 196 (97/99) | Confirmatory | | |
HOPE, 2000 | vitamin E | placebo | | 9541 (4761/4780) | Confirmatory | | |
ATBC vitamin E, 1994 | vitamin E | placebo | | 29133 (14564/14569) | Exploratory | | |
WACS vitamin E, 2007 | vitamin E | placebo | | 8171 (4083/4088) | Confirmatory | | NCT00000541 |
WHS vitamin E, 2005 | vitamin E | placebo | | 39876 (19937/19939) | Exploratory | | NCT00000479 |
PHS II vitamin E, 2008 | vitamin E | placebo | | 14641 (7315/7326) | Confirmatory | | NCT00270647 |
HOPE renal insufficiency subgroup, 2004 | vitamin E | placebo | | 993 (499/494) | Exploratory | | |
ASAP, 2000 | vitamin E | placebo | | 520 (260/260) | Exploratory | | |
ATBC 2nd prev subgroup (vitamin E), 1998 | vitamin E | placebo | | 1795 (916/879) | Exploratory | | |
AREDS, 2001 | vitamin E | placebo | | 4757 (2370/2387) | Exploratory | | |
Linxian, 1993 | vitamin E | placebo | | 29584 (14792/14792) | | | |
|
Hamilton, 1953 | | placebo | | 41 (20/21) | | | |
Livingstone, 1958 | | placebo | | 40 (20/20) | | | |